禁毒局面临针对MMJ生物制药的违宪做法的审查,这与以往的国防部问题相似。 DEA faces scrutiny for unconstitutional practices against MMJ BioPharma, similar to past DOL issues.

缉毒署(DEA)因使用类似于劳工局(DOL)在圣马力诺家庭案中的违宪做法而面临批评, The Drug Enforcement Agency (DEA) faces criticism for using unconstitutional practices similar to those of the Department of Labor (DOL) in the Marino family case, now against MMJ BioPharma Cultivation. MMJ BioPharma试图为临床试验生产林业发展局级的大麻,但多年来一直被缉毒局官僚主义的繁文缛节所缠绕,该局的官员担任调查员、检察官和法官。 MMJ BioPharma seeks to produce FDA-grade cannabis for clinical trials but has been entangled in bureaucratic red tape by the DEA for years, with the agency's officials acting as investigators, prosecutors, and judges. 这种模式对公司和潜在病人造成毁灭性后果,引起人们对联邦机构在宪法限制之外运作的关切。 This pattern has devastating consequences for the company and potential patients, raising concerns about federal agencies operating outside constitutional constraints. 最近的法律裁决表明,应当加紧审查这种做法,为改革铺平道路。 Recent legal rulings suggest increased scrutiny of such practices, potentially paving the way for reforms.